Hideyuki Wakamatsu

The usefulness of 18F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: comparison with 18F-FDG PET/CT

Shigeki Nagamachi, Ryuichi Nishii, Hideyuki Wakamatsu et al. · Annals of Nuclear Medicine · 2013 · 91 citations

Positron Emission Tomography, 18F-fdg Pet/ct, Engineering +10

Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non–insulin-dependent diabetes mellitus

Shigeki Nagamachi, Seigo Fujita, Ryuichi Nishii et al. · Journal of Nuclear Cardiology · 2006 · 79 citations

Non–insulin-dependent Diabetes, Cardiomyopathy, Cardiovascular Disease +8

Parathyroid scintigraphy with 99mTc-MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography

Hideyuki Wakamatsu, Shiro Noguchi, Hiroyuki Yamashita et al. · Nuclear Medicine Communications · 2003 · 75 citations

Positron Emission Tomography, Urology, Medical Imaging +15

Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with 99mTc-MIBI, 201Tl, MRI and US

Hideyuki Wakamatsu, Shiro Noguchi, Hiroyuki Yamashita et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 56 citations

Neuro-oncology, Technetium-99m Tetrofosmin, Medical Imaging +8

Associations between liver 18F fluoro-2-deoxy-d-glucose accumulation and various clinical parameters in a Japanese population: influence of the metabolic syndrome

Kiyohisa Kamimura, Shigeki Nagamachi, Hideyuki Wakamatsu et al. · Annals of Nuclear Medicine · 2010 · 48 citations

Obesity, Metabolic Syndrome, Japanese Population +13